Literature DB >> 33495885

Nocturia is Associated with High Atherosclerotic Cardiovascular Disease Risk in Women: Results from the National Health and Nutrition Examination Survey.

Jason M Lazar1, Muchi Ditah Chobufo2, Jeffrey P Weiss3, Karel Everaert4, Tine De Backer5, Alan J Wein6, F Charles Brunicardi7, Thomas F Monaghan3.   

Abstract

Growing evidence has identified nocturia as a potential manifestation of several cardiovascular disease states. We aimed to determine whether a relationship exists between nocturia and global atherosclerotic cardiovascular disease (ASCVD) risk, defined by the American College of Cardiology/American Heart Association (ACC/AHA) ASCVD risk calculator, using a large nationally-representative study sample from the United States. We explored potential associations between nocturia and ASCVD risk in adults aged 40-79 years with no prior history of overt/known atherosclerotic disease from 7 consecutive cycles of the National Health and Nutrition Examination Survey. Subjects were classified by whether they met the ASCVD high-risk threshold following current ACC/AHA consensus guidelines (10-year major adverse cardiovascular event risk ≥ 20%). Logistic regression analyses were used to explore associations between nocturia (defined as ≥ 2 nocturnal voids) and ASCVD risk. The prevalence of nocturia and high ASCVD risk were 27.0% and 10.9%, respectively. Nocturia, older age, increased body mass index, and diuretic use were associated with high ASCVD risk on univariate logistic regression. After adjusting for age, body mass index, and diuretic use, nocturia remained associated with significantly greater odds of high ASCVD risk in females but not in males. Elicitation of nocturia on clinical history taking may serve to identify high cardiovascular risk in females. Future studies are needed to elucidate mechanisms underlying this association.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular; LUTS; Marker; Nocturia

Year:  2021        PMID: 33495885     DOI: 10.1007/s10900-021-00962-9

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  21 in total

1.  Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey.

Authors:  Susan A Hall; Gretchen R Chiu; David W Kaufman; Gary A Wittert; Carol L Link; John B McKinlay
Journal:  BJU Int       Date:  2011-09-27       Impact factor: 5.588

2.  Nocturia: a marker of furosemide treatment response? An exploratory study.

Authors:  Thomas F Monaghan; Fred Gong; Michael Vaysblat; Christopher D George; Kyle P Michelson; Zhan D Wu; Christina W Agudelo; Donald L Bliwise; Karel Everaert; Jeffrey P Weiss; Richard Sadovsky; Alan J Wein; Jason M Lazar
Journal:  BJU Int       Date:  2020-01-27       Impact factor: 5.588

3.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

4.  Nocturia in relation to body mass index, smoking and some other life-style factors in women.

Authors:  R Asplund; H E Aberg
Journal:  Climacteric       Date:  2004-09       Impact factor: 3.005

5.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

6.  Nocturia is more bothersome than daytime LUTS: Results from an Observational, Real-life Practice Database including 8659 European and American LUTS patients.

Authors:  Karel Everaert; Peter Anderson; Robert Wood; Fredrik L Andersson; Tove Holm-Larsen
Journal:  Int J Clin Pract       Date:  2018-05-16       Impact factor: 2.503

7.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 8.  Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis.

Authors:  Iris I Bouwman; Maarten J H Voskamp; Boudewijn J Kollen; Rien J M Nijman; Wouter K van der Heide; Marco H Blanker
Journal:  World J Urol       Date:  2015-05-14       Impact factor: 4.226

9.  Analysis of the Prevalence and Factors Associated with Nocturia in Adult Korean Men.

Authors:  So Young Kim; Woojin Bang; Min-Su Kim; Bumjung Park; Jin-Hwan Kim; Hyo Geun Choi
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

10.  The Association Between Obesity and the Nocturia in the U.S. Population.

Authors:  Shinje Moon; Hye Soo Chung; Jae Myung Yu; Kwang Jin Ko; Don Kyoung Choi; Ohseong Kwon; Young Goo Lee; Sung Tae Cho
Journal:  Int Neurourol J       Date:  2019-06-30       Impact factor: 2.835

View more
  1 in total

1.  Family Physician's Educational Interview with Patients Helps in Early Recognition of Lower Urinary Tract Symptoms.

Authors:  Ana Lesac Brizić; Vladimir Mozetič
Journal:  Int J Gen Med       Date:  2021-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.